DSO Recap Logjam

A lot of dentists are hearing the same sloppy takeaway: private equity is done or recaps are over. The more useful version is narrower. Large recap events are jammed up by rate and leverage conditions, while the add-on market for attractive individual practices is still active.

Bottom line

Single-practice DSO demand is not dead

The episode's most useful correction is that smaller add-on acquisitions are still moving. The real slowdown is higher up the food chain, where larger DSO recapitalizations need deeper buyers and more debt capacity.

What is jammed

Recaps, not the whole market

When rates rise, the next buyer cannot lever enough debt to cash out the prior fund the way everyone modeled at lower-rate valuations. That creates the logjam people are feeling and misdescribing.

Why it matters

Doctors keep mixing up three different conversations

Individual practice sale demand, platform recap demand, and minority-liquidity events are not the same thing. If you mash them together, you end up with bad seller expectations and bad career reading.

The useful takeaways from the episode

Valuation pressure on attractive small-practice add-ons has not collapsed the way many dentists assume.
What changed materially is the recap market for larger PE-backed groups that need enough leverage for a full exit.
More minority or partial-liquidity transactions can happen when majority-buy debt does not pencil.
Groups can keep buying add-ons while still struggling to create liquidity for earlier investors.
Lower rates would likely loosen the recap market faster than they would radically change single-practice pricing.

Why dentists keep hearing that recaps are dead

Because several midsize and larger DSOs have been visibly stuck. That is real. But it does not mean private capital suddenly stopped wanting dental assets. It means the path to a clean majority recap is harder when debt is more expensive and buyers cannot lever the next transaction the same way.

That distinction matters. If you own one practice or a small group, you are not selling the same asset that a PE-backed platform is trying to recap. The buyer pool, leverage math, and investor-pressure dynamics are different.

OnlyDentists read

If you are a seller

Stop using recap gossip as your whole valuation model. Your practice can still be attractive even if some DSO holdco story is frozen upstream.

If you are taking equity rollover

This is where the episode really matters. You are exposed to timing risk, leverage risk, and liquidity risk you do not control. "We'll recap later" is not a magic sentence.

If you are building a group

Infrastructure matters. Once you move past a certain size, buyers stop paying you as if you are just a pile of good offices. They start asking whether the organization is actually built.

Practical caution points

Do not assume lower rates automatically mean your single practice gets a huge jump in value.
Do not treat a rollover-equity pitch like guaranteed future liquidity.
Do not confuse a strong add-on market with proof that a specific DSO is healthy.
Do not ignore the difference between a duct-taped group and a real operating platform.

Where the episode is strongest

It is strongest when it separates small-practice transaction demand from recap mechanics. That is the part most dentists miss. The market can still be active and still be jammed at the same time, depending on which layer of the stack you are talking about.

Sources

This page is an analysis note built from a podcast discussion, not an audited market database. It is useful because it explains the transaction logic clearly, not because one episode settles the DSO market forever.